Learning and Innovation Center (LINC) to draw thousands to Atlanta
ATLANTA, Sept. 23 – Elekta will unveil a state-of-the-art learning center at its North American headquarters, in conjunction with the 55th Annual Meeting of the American Society for Radiation Oncology (ASTRO) being held in Atlanta.
The Learning and Innovation Center (LINC) is expected to draw clinicians, researchers and health IT professionals to the city for education, training and collaboration on Elekta’s industry-leading solutions for treating cancer and brain disorders. The LINC also serves as a tangible introduction to Elekta, with interactive displays highlighting the company’s achievements in cancer treatment.
“The creation of the LINC consolidates a wealth of educational resources that encompass all of our cancer management competencies,” says Jay Hoey, Executive Vice President, Region North America. “Atlanta is an ideal location for this, with easy airport access to North America and the world, a thriving metropolitan area and a wealth of other health care and educational resources.”
The 25,000 square foot facility, set among a park-like setting, incorporates the latest adult learning principles and technology, and is equipped with actual working systems of virtually every Elekta solution to support hands-on learning. These solutions represent Elekta’s oncology, software, brachytherapy, neuroscience and imaging products, including the new Versa HD™ linear accelerator and Leksell Gamma Knife® Perfexion™. Enhancing the experience, students have access to the Versa HD vault, which is large enough for hands-on learning.
“This is a beautiful facility that brings numerous benefits to Atlanta and the State of Georgia,” says David Hartnett, Vice President, Economic Development, Bioscience-Health IT, Metro Atlanta Chamber. “Not only does it provide an ideal setting for learning, but the LINC has educational exhibits that demonstrate Elekta’s leadership in advancing cancer care. This facility enhances and solidifies Georgia’s leadership position in the fields of cancer treatment and research.”
# # #
The above information is such that Elekta AB (publ) shall make public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published at 15:00 CET on September 23, 2013.
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,500 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.